Vyatka biopharmaceutics: the project is almost ready
The design of the biotechnological production complex in the Kirov region will be completed in 2012.This was announced by the director of the Pharmaceutical Protection Center of the FMBA of Russia Viktor Nazarov.
The production complex will be built in the village . Levintsy, pharmaceutical substances and ready-made dosage forms of diagnostic and therapeutic proteins, including monoclonal antibodies and antibody-like proteins obtained using genetically engineered technologies, will be produced here.
The products are intended for the diagnosis and treatment of particularly dangerous infectious diseases, provision of blood services, protection of the population and specialists in emergency situations of chemical and radiation nature, for medical support of personnel at enterprises with particularly dangerous working conditions. In addition, within the framework of the import substitution program, it is planned to produce 5 medicines with a total annual import volume of more than $ 200 million. A separate block will create areas with low productivity for the introduction into production of innovative drugs developed at the Research Institute of the FMBA of Russia, as well as companies belonging to the pharmaceutical cluster "Severny", and specialists of VyatGU.
According to Viktor Nazarov, production facilities and laboratories with a total area of more than 15 thousand square meters will be built in Levintsy. The placement of pharmaceutical production on the basis of the Interuniversity Research Center for Collective Use is due to the fact that it was originally intended for work in the field of biotechnology, as well as the fact that it is provided with energy resources and transport accessibility. It is also of great importance that the administration of the Kirov region and the governor actively support this project. The leadership of Vyatka State University also supports him, which will be the base for training highly qualified personnel. In addition, the training of specialists will be conducted at the Moscow Institute of Physics and Technology. An agreement is being discussed between the Pharmaceutical Protection Research Center and Vyatka State University on the competitive selection of senior students for study and internship abroad.
According to Viktor Nazarov, the estimated cost of construction should not exceed 1988 million rubles, including design and survey work and purchase of equipment. Two–thirds of this amount will come from the budget of the Russian Federation, and one-third from extra-budgetary sources.
Lyudmila Ponomareva, FarmvestnikPortal "Eternal youth" http://vechnayamolodost.ru